These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 25270285)

  • 1. A genetic variant (rs17251221) in the calcium-sensing receptor relates to hepatocellular carcinoma susceptibility and clinical outcome treated by transcatheter hepatic arterial chemoembolization (TACE) therapy.
    Tang Q; Zhao Y; Wang Y; Wei M
    Med Oncol; 2014 Nov; 31(11):267. PubMed ID: 25270285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A genetic polymorphism (rs17251221) in the calcium-sensing receptor is associated with breast cancer susceptibility and prognosis.
    Li X; Kong X; Jiang L; Ma T; Yan S; Yuan C; Yang Q
    Cell Physiol Biochem; 2014; 33(1):165-72. PubMed ID: 24481145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A genetic polymorphism (rs17251221) in the calcium-sensing receptor is associated with ovarian cancer susceptibility.
    Yan S; Yuan C; Yang Q; Li X; Yang N; Liu X; Dong R; Zhang X; Yuan Z; Zhang N; Kong B
    Oncol Rep; 2015 Oct; 34(4):2151-5. PubMed ID: 26252839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of XRCC1/XPD/ERCC1 Polymorphisms in Predicting Prognosis of Hepatocellular Carcinoma in Patients Receiving Transcatheter Arterial Chemoembolization.
    Wang XC; Wang F; Quan QQ
    Genet Test Mol Biomarkers; 2016 Apr; 20(4):176-84. PubMed ID: 26918371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic variations in IDH gene as prognosis predictors in TACE-treated hepatocellular carcinoma patients.
    Zhang H; Guo X; Dai J; Wu Y; Ge N; Yang Y; Ji J; Zhang H
    Med Oncol; 2014 Nov; 31(11):278. PubMed ID: 25355558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic polymorphism of calcium-sensing receptor in women with breast cancer.
    Campos-Verdes LM; da Silva-Sampaio JP; Costa-Silva DR; de Oliveira VA; Junior AMC; Silva VC; Alencar AP; Campelo V; Lopes-Costa PV; Gebrim LH; da Silva BB
    Med Oncol; 2018 Jan; 35(3):23. PubMed ID: 29387985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A genetic polymorphism (rs17251221) in the calcium-sensing receptor gene (CASR) is associated with stone multiplicity in calcium nephrolithiasis.
    Chou YH; Woon PY; Chen WC; Hsu YW; Chang JM; Hwang DY; Chiu YC; Kuo HC; Chang WP; Hou MF; Liu ME; Chang JG; Chang WC
    PLoS One; 2011; 6(9):e25227. PubMed ID: 21966463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-28B variant as a predictor in patients with advanced hepatocellular carcinoma treated with hepatic arterial infusion chemotherapy.
    Terashima T; Honda M; Toyama T; Shimakami T; Shimizu R; Takatori H; Arai K; Kawaguchi K; Kitamura K; Yamashita T; Sakai Y; Yamashita T; Mizukoshi E; Kaneko S
    J Gastroenterol Hepatol; 2020 Oct; 35(10):1813-1820. PubMed ID: 32180251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A functional polymorphism in PER3 gene is associated with prognosis in hepatocellular carcinoma.
    Zhao B; Lu J; Yin J; Liu H; Guo X; Yang Y; Ge N; Zhu Y; Zhang H; Xing J
    Liver Int; 2012 Oct; 32(9):1451-9. PubMed ID: 22809120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic polymorphisms of immune checkpoint proteins PD-1 and TIM-3 are associated with survival of patients with hepatitis B virus-related hepatocellular carcinoma.
    Li Z; Li N; Li F; Zhou Z; Sang J; Jin Z; Liu H; Han Q; Lv Y; Liu Z
    Oncotarget; 2016 May; 7(18):26168-80. PubMed ID: 27034168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic Polymorphism of Epidermal Growth Factor Gene as a Predictor of Hepatocellular Carcinoma in Hepatitis C Cirrhotic Patients.
    Baghdadi I; Abu Ella K; El Shaaraway A; Elshayeb E; El-Rebey HS; El Hoseeny M; Naguib M; Nada A
    Asian Pac J Cancer Prev; 2020 Jul; 21(7):2047-2053. PubMed ID: 32711431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional polymorphisms in the NPAS2 gene are associated with overall survival in transcatheter arterial chemoembolization-treated hepatocellular carcinoma patients.
    Yuan P; Wang S; Zhou F; Wan S; Yang Y; Huang X; Zhang Z; Zhu Y; Zhang H; Xing J
    Cancer Sci; 2014 Jul; 105(7):825-32. PubMed ID: 24754267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variants in the KDR gene is associated with the prognosis of transarterial chemoembolization treated hepatocellular carcinoma.
    Zheng YB; Huang JW; Zhan MX; Zhao W; Liu B; He X; Li Y; Hu BS; Lu LG
    Tumour Biol; 2014 Nov; 35(11):11473-81. PubMed ID: 25123269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NOD1 and NOD2 genetic variants: Impact on hepatocellular carcinoma susceptibility and progression in Moroccan population.
    Zerrad C; Lkhider M; Bouqdayr M; Belkouchi A; Badre W; Tahiri M; Pineau P; Benjelloun S; Ezzikouri S
    Gene; 2024 Dec; 931():148847. PubMed ID: 39147112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
    Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
    Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Case-Control Study on the Correlation Between Thymidylate Synthase Gene Polymorphisms and Raltitrexed Treatment Combined with Transcatheter Arterial Chemoembolization in Hepatocellular Carcinoma Treatment.
    Qi C; Gao H; Li S; Zong H; Hao H; Zhang L
    Genet Test Mol Biomarkers; 2020 Mar; 24(3):156-164. PubMed ID: 32101052
    [No Abstract]   [Full Text] [Related]  

  • 17. The safety and efficacy of balloon-occluded transcatheter arterial chemoembolization for hepatocellular carcinoma refractory to conventional transcatheter arterial chemoembolization.
    Kim PH; Gwon DI; Kim JW; Chu HH; Kim JH
    Eur Radiol; 2020 Oct; 30(10):5650-5662. PubMed ID: 32409860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA Gene Polymorphisms in Evaluating Therapeutic Efficacy After Transcatheter Arterial Chemoembolization for Primary Hepatocellular Carcinoma.
    Qiu GP; Liu J
    Genet Test Mol Biomarkers; 2016 Oct; 20(10):579-586. PubMed ID: 27525669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression quantitative trait loci for PAX8 contributes to the prognosis of hepatocellular carcinoma.
    Ma S; Yang J; Song C; Ge Z; Zhou J; Zhang G; Hu Z
    PLoS One; 2017; 12(3):e0173700. PubMed ID: 28339471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of MicroRNA 196a and 499 Polymorphisms with Development of Cirrhosis and Hepatocellular Carcinoma Post-HCV Infection in Egyptian Patients.
    Fteah AM; Ahmed AI; Mosaad NA; Hassan MM; Mahmoud SH
    Asian Pac J Cancer Prev; 2019 Nov; 20(11):3479-3485. PubMed ID: 31759375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.